Complement evasion strategies of pathogens-acquisition of inhibitors and beyond.
Activation of the complement system and resulting opsonisation with C3b are key events of the innate immune defense against infections. However, a wide variety of bacterial pathogens subvert complement attack by binding host complement inhibitors such as C4b-binding protein, factor H and vitronectin, which results in diminished opsonophagocytosis and killing of bacteria by lysis. Another widely used strategy is production of proteases, which can effectively degrade crucial complement components. Furthermore, bacterial pathogens such as Moraxella catarrhalis and Staphylococcus aureus capture and incapacitate the key complement component C3. The current review describes examples of these three strategies. Targeting binding sites for complement inhibitors on bacterial surfaces and complement-degrading proteases with vaccine-induced antibodies may be used to enhance a common vaccine design strategy that depends on the generation of complement-dependent bactericidal and opsonophagocytic antibody activities.
Blom
Anna M
AM
Lund University, Deptartment of Laboratory Medicine, University Hospital Malmö, Sweden. Anna.Blom@med.lu.se
Hallström
Teresia
T
Riesbeck
Kristian
K
D000818:Animals; D001419:Bacteria / Q000276:immunology* / Q000472:pathogenicity; D003167:Complement Activation; D003176:Complement C3 / Q000037:antagonists & inhibitors / Q000276:immunology*; D050716:Complement C4b-Binding Protein; D017242:Complement Factor H / Q000276:immunology; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D010447:Peptide Hydrolases / Q000276:immunology; D010587:Phagocytosis; D019096:Vitronectin / Q000276:immunology
C055609:C4BPA protein, human; D003176:Complement C3; D050716:Complement C4b-Binding Protein; D006649:Histocompatibility Antigens; D019096:Vitronectin; D017242:Complement Factor H; D010447:Peptide Hydrolases